What is Dolby Laboratories, Inc.'s allowance for credit losses on financing receivables?

Dolby Laboratories, Inc. (DLB) reported allowance for credit losses on financing receivables of $83K in Q1 2026.

How has Dolby Laboratories, Inc.'s allowance for credit losses on financing receivables changed year-over-year?

Dolby Laboratories, Inc.'s allowance for credit losses on financing receivables decreased by 13.5% year-over-year, from $96K to $83K.

Revenue$395.6M+7.1%

Gross profit$350.9M+5.1%

Operating income$112.9M+4.8%

Net income$94.9M+3.4%

EPS (diluted)$0.99+5.3%

Cash & equivalents$673.8M-10.2%

Total debt$49.7M+22.9%

Total equity$2.6B+1.7%

Total assets$3.2B+0.6%

Operating cash flow$92.5M-47.1%

CapEx$9.1M+31.4%

Free cash flow$83.4M-50.3%

Market cap$4.95B-25.9%

Gross margin87.4%-1.5pp

Operating margin18.5%-2.0pp

Net margin17.9%-1.6pp

FCF margin22.1%-7.5pp

Return on equity9.4%-0.9pp

Debt / equity0×0.0×

Current ratio3×-0.1×

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss.

The official record: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

What is Dolby Laboratories, Inc.'s allowance for credit losses on financing receivables?: Dolby Laboratories, Inc. (DLB) reported allowance for credit losses on financing receivables of $83K in Q1 2026.
How has Dolby Laboratories, Inc.'s allowance for credit losses on financing receivables changed year-over-year?: Dolby Laboratories, Inc.'s allowance for credit losses on financing receivables decreased by 13.5% year-over-year, from $96K to $83K.